Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Is US Hemp Policy Heading For Farm Bill, Act III?

Jan 27 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry

Jan 27 2023

Hemp Supplement Sales Continue In US Without FDA Acknowledgement As Lawful Products

Jan 26 2023

Heightening Focus On Hemp, Cannabis, US FDA Hires Norman Birenbaum As Public Health Advisor

Sep 30 2022

CBD Will Be US FDA’s ‘One’ Lawful Hemp Compound, House Appropriators Anticipate

Jul 13 2022

‘Rope Not Dope’ Still Convince Congress On Hemp?

Nov 06 2022

House Appropriators Stoke Flames For FDA Regulation On CBD In Supplements

Mar 01 2019

FDA Road To Decision On Expanding CBD Uses Starts With Weighing Impact On Existing And Future Use As Drug

Jun 03 2019

Continuing FDA Regulation Doesn't Dampen Cannabis Investment Enthusiasm

Dec 28 2018

More from Archive

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window